Molecular Pharmacology

Research Frontiers in Phosphoinositide Three Kinase Isoform Selectivity

Design of PI3K isoform-selective inhibitors to differentially target cancer cells and immune cells while minimizing metabolic toxicity.

All Molecular Pharmacology PhD categories